Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by lscfaon Nov 12, 2021 9:07am
521 Views
Post# 34118846

RE:RE:RE:RE:Sorry to see Quipt Downgrade - Ms. Stellick cut her target

RE:RE:RE:RE:Sorry to see Quipt Downgrade - Ms. Stellick cut her target

Avg analyst forecasts... 
 

Revenue

2021

2022

Increase

Quipt

128

163

27.3%

Viemed

143

158

10.5%

Apria

1140

1200

5.3%

Adapthealth

2440

2850

16.8%

 



lscfa wrote:

IA forecasts $134 million revenue for F22, dumbass.....


 

Carlito3311 wrote: the targets make no sense.  that implies close to a US$400 million enterprise value for just over $100mm net revenues.  this is expensive at 2x net revenues, let alone 4x.
so you can buy mom n pops at 0.8x revenues and then the makets will value it at 4x?  no chance.


 

 

 



<< Previous
Bullboard Posts
Next >>